Discrimination and the Brain-Gut-Microbiome (BGM) Axis
Social Isolation and Discrimination as Stressors Influencing BGM Alterations
1 other identifier
observational
266
1 country
1
Brief Summary
Obesity is a major public health problem related to a variety of illnesses such as heart disease and diabetes. Prior research indicates that social stressors contribute to risk for obesity, possibly through alterations in diet and physical activity. However, it is not fully clear how these alterations contribute to obesity. The purpose of this study is to examine how the stressors of social isolation and discrimination relate to eating behaviors and dietary patterns, and further, how these behaviors affect the brain-gut-microbiome (BGM) connections. This study will focus on Mexican and Filipina women because research shows that they encounter a high burden of obesity and exposure to social stressors. Approximately 300 Mexican and Filipina women will be screened and enrolled. They will then provide information about social stressors via food diaries, physical body measures (e.g. waist circumference), questionnaire data regarding diet and eating behaviors, and measures of physical activity. Stool and serum will be collected to analyze microbes and metabolomics, and MRI to assess brain changes in the reward network. Analytic techniques will be used to integrate data from these multiple data sources. This analysis will determine the unique differences associated with ethnicity and social stressors in moderating eating behaviors and dietary patterns. The results of this study will provide new information about a possible pathway whereby social stressors affect behavioral, neurological and microbiome mechanisms related to obesity risk and provide new information in BGM patterns in two understudied ethnic groups. In the long term, this research may suggest possible approaches for intervention that may help reduce inequalities in obesity and related health problems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 24, 2021
CompletedFirst Submitted
Initial submission to the registry
October 21, 2021
CompletedFirst Posted
Study publicly available on registry
November 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJanuary 10, 2025
January 1, 2025
3.4 years
October 21, 2021
January 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Multimodal Brain Signatures
Neuroimaging of participants brain via MRI procedure.
Measured once at Visit 2. Scan lasts about 1.5 hour.
Microbiome - Stool
Measurement of 16S RNA, shotgun metagenomics, and metabolomics via stool specimen.
Collected twice by the participant at home between Visit 1 and Visit 2, lasting no more than 2 weeks after the first appointment.
Microbiome - Blood
Measurement of 16S RNA, shotgun metagenomics, and metabolomics via blood specimen.
Collected once at Day1.
Secondary Outcomes (8)
Systolic and Diastolic Blood Pressure
Measured once at Day 1.
Questionnaire Data - Diet
Self-reported by the participant at home between Visit 1 and Visit 2, lasting no more than 2 weeks after the first appointment.
Questionnaire Data - Stressors
Self-reported by the participant at home between Visit 1 and Visit 2, lasting no more than 2 weeks after the first appointment.
Anthropometrics - waist & hip circumference
Measured once at Day 1.
Anthropometrics - BMI
Measured once at Day 1.
- +3 more secondary outcomes
Other Outcomes (3)
Differences in Multimodal Brain Signatures
Measured at optional follow up visit at 3 and/or 6 month mark. Scan lasts about 1.5 hour.
Differences in Microbiome - Stool
Collected twice by the participant at home before the 3 and/or 6 month follow up appointment, occurring approximately 3 and 6 months after the second (MRI) appointment.
Differences in Microbiome - Blood
Collected once at the 3 and/or 6month follow up appointment, occurring approximately 3 and 6months after the second (MRI) appointment.
Study Arms (2)
Mexican Women
Mexican, premenopausal women ages 18-50.
Filipina Women
Filipina, premenopausal women ages 18-50.
Eligibility Criteria
Participants recruited from the greater Los Angeles Mexican \& Filipina female population.
You may qualify if:
- Premenopausal females
- Ages 18-50
- Mexican or Filipino ancestry
- BMI 19-40
- Fluent in English
- Right-handed
You may not qualify if:
- Co-Morbidities including but not limited to:
- Type I diabetes (insulin dependent)
- Vascular disease
- Drastic weight loss (more than 10lbs over the preceding 2months)
- Frequent Strenuous exercise (i.e. marathon runners/heavy weight lifting)
- Abdominal surgeries including weight loss surgery, or partial/complete resection of the stomach or bowel
- Untreated thyroid disease
- Neurological disease
- Major medical condition that may put the subject at risk or interfere with data collection as determined by the PI/MD
- Chronic pain
- Diagnosed DSM IV active psychiatric illness including eating disorders. Must not be active or present for at least 2 years.
- Use of medications known to affect hunger, satiety, and/or appetite.
- Unable to safely participate in the MRI (claustrophobia, presence of devices affected by MRI such as pacemakers, neurostimulators, or any metallic foreign body, etc.)
- Pregnant, lactating, postpartum less than 6mo
- Women of childbearing age who are not practicing birth control or are planning to get pregnant during the study.
- +20 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, Los Angeles
Los Angeles, California, 90095, United States
Biospecimen
Stool and plasma are collected.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Arpana Gupta, PhD
The Regents of the University of California, Los Angeles
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 21, 2021
First Posted
November 16, 2021
Study Start
August 24, 2021
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
January 10, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
At this time there is no plan to make the de-identified data available for sharing with other researchers.